Coexpression cluster:C531
From FANTOM5_SSTAR
Full id: C531_Neutrophils_Eosinophils_large_CD14_rectal_epitheloid_Hep2
Phase1 CAGE Peaks
Hg19::chr11:3818756..3818793,- | p1@NUP98 |
Hg19::chr1:207495013..207495037,+ | p1@CD55 |
Hg19::chr1:207495772..207495786,+ | p7@CD55 |
Hg19::chr1:207495790..207495803,+ | p17@CD55 |
Hg19::chr1:207495844..207495859,+ | p14@CD55 |
Hg19::chr1:207497905..207497939,+ | p3@CD55 |
Hg19::chr1:207497946..207497958,+ | p11@CD55 |
Hg19::chr1:207497988..207498028,+ | p4@CD55 |
Hg19::chr1:207498974..207498994,+ | p9@CD55 |
Hg19::chr1:207498999..207499011,+ | p13@CD55 |
Hg19::chr1:207499012..207499044,+ | p5@CD55 |
Hg19::chr1:207500090..207500105,+ | p6@CD55 |
Hg19::chr1:207504446..207504457,+ | p@chr1:207504446..207504457 + |
Hg19::chr1:207504490..207504510,+ | p@chr1:207504490..207504510 + |
Hg19::chr1:207504564..207504579,+ | p@chr1:207504564..207504579 + |
Hg19::chr1:207504605..207504622,+ | p@chr1:207504605..207504622 + |
Hg19::chr1:207510129..207510165,- | p@chr1:207510129..207510165 - |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006999 | nuclear pore organization and biogenesis | 0.0122744532210089 |
GO:0045730 | respiratory burst | 0.0122744532210089 |
GO:0017056 | structural constituent of nuclear pore | 0.0190924697548727 |
GO:0000059 | protein import into nucleus, docking | 0.0218419002159206 |
GO:0006958 | complement activation, classical pathway | 0.0218419002159206 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 0.0218419002159206 |
GO:0006997 | nuclear organization and biogenesis | 0.0218419002159206 |
GO:0006956 | complement activation | 0.0218419002159206 |
GO:0002541 | activation of plasma proteins during acute inflammatory response | 0.0218419002159206 |
GO:0045121 | lipid raft | 0.0218419002159206 |
GO:0016064 | immunoglobulin mediated immune response | 0.0218419002159206 |
GO:0019724 | B cell mediated immunity | 0.0218419002159206 |
GO:0043623 | cellular protein complex assembly | 0.0218419002159206 |
GO:0065002 | intracellular protein transport across a membrane | 0.0218419002159206 |
GO:0051480 | cytosolic calcium ion homeostasis | 0.0218419002159206 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 0.0218419002159206 |
GO:0002253 | activation of immune response | 0.0218419002159206 |
GO:0002449 | lymphocyte mediated immunity | 0.0218419002159206 |
GO:0006959 | humoral immune response | 0.0218419002159206 |
GO:0002250 | adaptive immune response | 0.0218419002159206 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0218419002159206 |
GO:0002443 | leukocyte mediated immunity | 0.0218419002159206 |
GO:0002526 | acute inflammatory response | 0.0218419002159206 |
GO:0051028 | mRNA transport | 0.0218419002159206 |
GO:0050778 | positive regulation of immune response | 0.0218419002159206 |
GO:0002684 | positive regulation of immune system process | 0.0218419002159206 |
GO:0005643 | nuclear pore | 0.0218419002159206 |
GO:0050658 | RNA transport | 0.0218419002159206 |
GO:0051236 | establishment of RNA localization | 0.0218419002159206 |
GO:0050657 | nucleic acid transport | 0.0218419002159206 |
GO:0006403 | RNA localization | 0.0218419002159206 |
GO:0006606 | protein import into nucleus | 0.0218419002159206 |
GO:0046930 | pore complex | 0.0218419002159206 |
GO:0050776 | regulation of immune response | 0.0218419002159206 |
GO:0051170 | nuclear import | 0.0218419002159206 |
GO:0002682 | regulation of immune system process | 0.0218419002159206 |
GO:0015931 | nucleobase, nucleoside, nucleotide and nucleic acid transport | 0.0218419002159206 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0218419002159206 |
GO:0002252 | immune effector process | 0.0218419002159206 |
GO:0044453 | nuclear membrane part | 0.0218419002159206 |
GO:0045087 | innate immune response | 0.0218419002159206 |
GO:0006874 | cellular calcium ion homeostasis | 0.0218419002159206 |
GO:0055074 | calcium ion homeostasis | 0.0218419002159206 |
GO:0017038 | protein import | 0.0218419002159206 |
GO:0006875 | cellular metal ion homeostasis | 0.0218419002159206 |
GO:0055065 | metal ion homeostasis | 0.0218419002159206 |
GO:0048503 | GPI anchor binding | 0.0218976048652095 |
GO:0031965 | nuclear membrane | 0.02547336752759 |
GO:0006913 | nucleocytoplasmic transport | 0.02547336752759 |
GO:0051169 | nuclear transport | 0.02547336752759 |
GO:0030005 | cellular di-, tri-valent inorganic cation homeostasis | 0.0287214589601625 |
GO:0055066 | di-, tri-valent inorganic cation homeostasis | 0.0287214589601625 |
GO:0005635 | nuclear envelope | 0.0298685474727805 |
GO:0030003 | cellular cation homeostasis | 0.0301136843778026 |
GO:0055080 | cation homeostasis | 0.0301136843778026 |
GO:0006605 | protein targeting | 0.0317543212284013 |
GO:0005625 | soluble fraction | 0.0327573563177623 |
GO:0055082 | cellular chemical homeostasis | 0.0327573563177623 |
GO:0006873 | cellular ion homeostasis | 0.0327573563177623 |
GO:0035091 | phosphoinositide binding | 0.0341071295173144 |
GO:0050801 | ion homeostasis | 0.0356780789030172 |
GO:0051239 | regulation of multicellular organismal process | 0.0364119499824043 |
GO:0006954 | inflammatory response | 0.0376372976168732 |
GO:0048878 | chemical homeostasis | 0.0384434488269865 |
GO:0005543 | phospholipid binding | 0.041843015573562 |
GO:0006461 | protein complex assembly | 0.0419455896578316 |
GO:0006260 | DNA replication | 0.0431328841847652 |
GO:0019725 | cellular homeostasis | 0.0448795788258851 |
GO:0009893 | positive regulation of metabolic process | 0.0461053402929223 |
GO:0009611 | response to wounding | 0.0491428245464635 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
classical monocyte | 5.30e-24 | 42 |
CD14-positive, CD16-negative classical monocyte | 5.30e-24 | 42 |
defensive cell | 5.79e-20 | 48 |
phagocyte | 5.79e-20 | 48 |
myeloid leukocyte | 3.74e-18 | 72 |
granulocyte monocyte progenitor cell | 1.33e-15 | 67 |
leukocyte | 1.69e-15 | 136 |
myeloid lineage restricted progenitor cell | 1.78e-15 | 66 |
myeloid cell | 2.84e-15 | 108 |
common myeloid progenitor | 2.84e-15 | 108 |
macrophage dendritic cell progenitor | 5.64e-15 | 61 |
monopoietic cell | 6.60e-14 | 59 |
monocyte | 6.60e-14 | 59 |
monoblast | 6.60e-14 | 59 |
promonocyte | 6.60e-14 | 59 |
hematopoietic stem cell | 3.04e-13 | 168 |
angioblastic mesenchymal cell | 3.04e-13 | 168 |
hematopoietic oligopotent progenitor cell | 3.06e-13 | 161 |
hematopoietic multipotent progenitor cell | 3.06e-13 | 161 |
hematopoietic lineage restricted progenitor cell | 7.77e-13 | 120 |
hematopoietic cell | 1.03e-11 | 177 |
nongranular leukocyte | 3.16e-11 | 115 |
stuff accumulating cell | 1.52e-07 | 87 |
Ontology term | p-value | n |
---|---|---|
hematopoietic system | 7.30e-14 | 98 |
blood island | 7.30e-14 | 98 |
hemolymphoid system | 1.12e-12 | 108 |
bone marrow | 2.67e-11 | 76 |
bone element | 5.72e-11 | 82 |
immune system | 1.13e-09 | 93 |
skeletal element | 1.56e-08 | 90 |
larynx | 5.35e-08 | 9 |
skeletal system | 1.12e-07 | 100 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.000498485 |
MA0004.1 | 0.221943 |
MA0006.1 | 0.112549 |
MA0007.1 | 0.208008 |
MA0009.1 | 0.621697 |
MA0014.1 | 0.00118158 |
MA0017.1 | 0.137108 |
MA0019.1 | 0.340029 |
MA0024.1 | 0.525161 |
MA0025.1 | 0.747404 |
MA0027.1 | 2.20546 |
MA0028.1 | 0.122394 |
MA0029.1 | 0.542771 |
MA0030.1 | 0.532314 |
MA0031.1 | 0.474026 |
MA0038.1 | 0.302644 |
MA0040.1 | 0.548121 |
MA0041.1 | 0.236024 |
MA0042.1 | 0.608306 |
MA0043.1 | 0.621991 |
MA0046.1 | 1.48543 |
MA0048.1 | 0.0140676 |
MA0050.1 | 0.212584 |
MA0051.1 | 0.299199 |
MA0052.1 | 0.551663 |
MA0055.1 | 0.00123747 |
MA0056.1 | 0 |
MA0057.1 | 0.0616251 |
MA0058.1 | 0.153757 |
MA0059.1 | 0.15289 |
MA0060.1 | 0.0509127 |
MA0061.1 | 0.0397345 |
MA0063.1 | 0 |
MA0066.1 | 2.26462 |
MA0067.1 | 0.924196 |
MA0068.1 | 0.0264141 |
MA0069.1 | 0.607975 |
MA0070.1 | 0.597583 |
MA0071.1 | 0.27142 |
MA0072.1 | 0.593415 |
MA0073.1 | 0.000460837 |
MA0074.1 | 0.298586 |
MA0076.1 | 0.164578 |
MA0077.1 | 0.586275 |
MA0078.1 | 2.6496 |
MA0081.1 | 0.152999 |
MA0083.1 | 0.628701 |
MA0084.1 | 1.10674 |
MA0087.1 | 0.591148 |
MA0088.1 | 0.00460154 |
MA0089.1 | 0 |
MA0090.1 | 0.174619 |
MA0091.1 | 0.636604 |
MA0092.1 | 0.195947 |
MA0093.1 | 0.114388 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.314026 |
MA0101.1 | 0.116395 |
MA0103.1 | 0.34743 |
MA0105.1 | 0.0103933 |
MA0106.1 | 0.33677 |
MA0107.1 | 0.0748038 |
MA0108.2 | 0.471286 |
MA0109.1 | 0 |
MA0111.1 | 0.184188 |
MA0113.1 | 0.924932 |
MA0114.1 | 0.072201 |
MA0115.1 | 0.850405 |
MA0116.1 | 0.0765991 |
MA0117.1 | 0.656858 |
MA0119.1 | 0.142224 |
MA0122.1 | 0.681203 |
MA0124.1 | 0.810546 |
MA0125.1 | 1.73305 |
MA0130.1 | 0 |
MA0131.1 | 0.398042 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 2.64878 |
MA0136.1 | 0.30842 |
MA0139.1 | 0.0351037 |
MA0140.1 | 0.269307 |
MA0141.1 | 0.151722 |
MA0142.1 | 0.445733 |
MA0143.1 | 0.350722 |
MA0144.1 | 0.0651126 |
MA0145.1 | 0.00588885 |
MA0146.1 | 7.9117e-05 |
MA0147.1 | 0.0784275 |
MA0148.1 | 0.240905 |
MA0149.1 | 0.261654 |
MA0062.2 | 0.0377014 |
MA0035.2 | 0.268747 |
MA0039.2 | 0.00269755 |
MA0138.2 | 0.38342 |
MA0002.2 | 0.393994 |
MA0137.2 | 0.398112 |
MA0104.2 | 0.188874 |
MA0047.2 | 0.326636 |
MA0112.2 | 1.0853 |
MA0065.2 | 0.00623543 |
MA0150.1 | 0.170499 |
MA0151.1 | 0 |
MA0152.1 | 0.753898 |
MA0153.1 | 1.69994 |
MA0154.1 | 0.00994595 |
MA0155.1 | 0.0782503 |
MA0156.1 | 0.12788 |
MA0157.1 | 0.421609 |
MA0158.1 | 0 |
MA0159.1 | 0.0787617 |
MA0160.1 | 0.703717 |
MA0161.1 | 0 |
MA0162.1 | 0.00317087 |
MA0163.1 | 0.000152387 |
MA0164.1 | 0.361105 |
MA0080.2 | 0.11444 |
MA0018.2 | 0.337929 |
MA0099.2 | 0.27482 |
MA0079.2 | 5.83152e-08 |
MA0102.2 | 1.14323 |
MA0258.1 | 0.82387 |
MA0259.1 | 0.0828875 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
POLR2A#5430 | 17 | 2.14745317655807 | 2.27473247069268e-06 | 8.12763546037197e-05 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.